Francis Giraud

Clermont-ferrand, 63000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Recent developments in Haspin kinase inhibitors: Structure, synthesis and activities.

Recent developments in Haspin kinase inhibitors: Structure, synthesis and activities.

Journal: Bioorganic & medicinal chemistry

Published: March 03, 2026

Synthesis of 1H-Pyrrolo[3,2-g]isoquinoline Derivatives as Ligands Targeting Haspin Kinase.

Synthesis of 1H-Pyrrolo[3,2-g]isoquinoline Derivatives as Ligands Targeting Haspin Kinase.

Journal: Molecules (Basel, Switzerland)

Published: September 26, 2025

Synthesis and biological activity of 1H-pyrrolo[3,2-g]isoquinolines as Haspin kinase inhibitors.

Synthesis and biological activity of 1H-pyrrolo[3,2-g]isoquinolines as Haspin kinase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: December 02, 2024

Liposomes loaded with daunorubicin and an emetine prodrug for improved selective cytotoxicity towards acute myeloid leukaemia cells.

Liposomes loaded with daunorubicin and an emetine prodrug for improved selective cytotoxicity towards acute myeloid leukaemia cells.

Journal: International journal of pharmaceutics

Published: June 07, 2024

Synthesis of diversely substituted pyridin-2(1H)-ones and in vivo evaluation of their anti-allodynic effect on cutaneous inflammatory mechanical allodynia.

Synthesis of diversely substituted pyridin-2(1H)-ones and in vivo evaluation of their anti-allodynic effect on cutaneous inflammatory mechanical allodynia.

Journal: RSC medicinal chemistry

Published: May 22, 2024

The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells.

The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells.

Journal: Cancers

Published: December 30, 2023

Synthesis and biological evaluation of 1H-pyrrolo[3,2-g]isoquinolines.

Synthesis and biological evaluation of 1H-pyrrolo[3,2-g]isoquinolines.

Journal: Bioorganic & medicinal chemistry

Published: December 22, 2023

Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles.

Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles.

Journal: European journal of medicinal chemistry

Published: December 20, 2023

Synthesis and Kinase Inhibitory Potencies of Pyrazolo[3,4-g]isoquinolines.

Synthesis and Kinase Inhibitory Potencies of Pyrazolo[3,4-g]isoquinolines.

Journal: Molecules (Basel, Switzerland)

Published: July 18, 2022

Synthesis of new pyrazolo[4,3-a]phenanthridine Pim-1 inhibitors and evaluation of their cytotoxic activity towards the MOLM-13 acute myeloid leukemia cell line.

Synthesis of new pyrazolo[4,3-a]phenanthridine Pim-1 inhibitors and evaluation of their cytotoxic activity towards the MOLM-13 acute myeloid leukemia cell line.

Journal: Bioorganic & medicinal chemistry letters

Published: June 07, 2022

Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity.

Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity.

Journal: European journal of medicinal chemistry

Published: March 15, 2022

Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.

Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.

Journal: Nature cell biology

Published: July 05, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026